Universidade Estadual de Campinas (Unicamp), Faculdade de Ciências Médicas, Laboratório para o Estudo Mineral e Ósseo em Nefrologia (LEMON), Campinas, SP, Brazil.
Universidade Estadual de Campinas (Unicamp), Faculdade de Ciências Médicas, Departamento de Clínica Médica, Divisão de Nefrologia, Campinas, SP, Brazil.
J Bras Nefrol. 2024 Apr 29;46(3):e20240023. doi: 10.1590/2175-8239-JBN-2024-0023en. eCollection 2024.
In the last few years, evidence from the Brazilian Registry of Bone Biopsy (REBRABO) has pointed out a high incidence of aluminum (Al) accumulation in the bones of patients with CKD under dialysis. This surprising finding does not appear to be merely a passive metal accumulation, as prospective data from REBRABO suggest that the presence of Al in bone may be independently associated with major adverse cardiovascular events. This information contrasts with the perception of epidemiologic control of this condition around the world. In this opinion paper, we discussed why the diagnosis of Al accumulation in bone is not reported in other parts of the world. We also discuss a range of possibilities to understand why bone Al accumulation still occurs, not as a classical syndrome with systemic signs of intoxication, as occurred it has in the past.
在过去的几年中,巴西骨活检登记处(REBRABO)的证据指出,在接受透析的 CKD 患者的骨骼中,铝(Al)的积累发生率很高。这一令人惊讶的发现似乎不仅仅是一种被动的金属积累,因为来自 REBRABO 的前瞻性数据表明,骨骼中存在 Al 可能与主要不良心血管事件独立相关。这一信息与世界各地对这种情况的流行病学控制的看法形成了对比。在这篇观点文章中,我们讨论了为什么在世界其他地方没有报告骨骼中 Al 积累的诊断。我们还讨论了一系列可能性,以了解为什么骨骼 Al 积累仍然会发生,而不是像过去那样出现全身性中毒迹象的经典综合征。